SQI Diagnostics and its subsidiaries are currently working on the development of 21 products that fall under the In Vitro Diagnostics markets. GlobalData’s report SQI Diagnostics Medical Device Development provides an overview of the company’s pipeline landscape and offers detailed analysis of its products in development. Buy the report here.
The company’s devices in development are in the late stage of development.
The main research and development focus of SQI Diagnostics is on immune system diseases, followed by digestive system diseases, infectious diseases, hematologic diseases, respiratory tract diseases, cardiovascular diseases, hormonal disorders and urologic diseases.
SQI Diagnostics: Top therapeutic area(s) by pipeline products
For a complete picture of the developmental pipeline for SQI Diagnostics medical devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.